FLT3 Inhibitor XY0206

**Semantic type:** Pharmacologic Substance

**Definition:** A selective inhibitor of FMS-like tyrosine kinase 3 (FLT3; CD135; STK1; FLK2) with potential antineoplastic activity. Upon administration, FLT3 inhibitor XY0206 targets, binds to and inhibits the activity of FLT3. This inhibits the proliferation of FLT3-expressing cancer cells. FLT3, a class III receptor tyrosine kinase (RTK), is overexpressed or mutated in most B-lineage neoplasms and in acute myeloid leukemias.

**Synonyms:** - NMS03592088 - XY 0206 - XY-0206 - XY0206